Homeinvestor healthcare

investor healthcare

Iovance Biotherapeutics, Inc. Sets Prices for $50 Million Common Stock Offering

Iovance Biotherapeutics, Inc. Sets Prices for $50 Million Common Stock Offering

September 21, 2017

Zacks Investment Research Upgrades VBI Vaccines, Inc.’s Rating

Zacks Investment Research Upgrades VBI Vaccines, Inc.’s Rating

September 21, 2017

Impax Laboratories in Talks About Merger with Amneal Pharmaceuticals LLC

Impax Laboratories in Talks About Merger with Amneal Pharmaceuticals LLC

September 21, 2017

VBI Vaccines’ Rating Upgraded by Zacks Investment Research

VBI Vaccines’ Rating Upgraded by Zacks Investment Research

September 20, 2017

Zacks Investment Research Upgrades OraSure Technologies Stock Rating

Zacks Investment Research Upgrades OraSure Technologies Stock Rating

September 20, 2017

Cantor Fitzgerald Global Healthcare Conference to Feature Presentation from OraSure Technologies

Cantor Fitzgerald Global Healthcare Conference to Feature Presentation from OraSure Technologies

September 20, 2017

This is Why Right Now is the Best Time to Buy Iovance Biotherapeutics

This is Why Right Now is the Best Time to Buy Iovance Biotherapeutics

September 19, 2017

Nabriva Therapeutics Stock Increased Today, Here’s Why

Nabriva Therapeutics Stock Increased Today, Here’s Why

September 19, 2017

The Road Ahead for Spectrum Pharmaceuticals, Inc.

The Road Ahead for Spectrum Pharmaceuticals, Inc.

September 19, 2017

The Recipe Behind Abeona Therapeutics’ 6 Months Dominance

The Recipe Behind Abeona Therapeutics’ 6 Months Dominance

September 18, 2017

« 1 … 16 17 18 19 20 … 22 »